Cargando…

Management of PALB2‐associated breast cancer: A literature review and case report

Germline pathogenic variants (PV) of the PALB2 tumor suppressor gene are associated with an increased risk of breast, pancreatic, and ovarian cancer. In previous research, PALB2‐associated breast cancer showed aggressive clinicopathological phenotypes, particularly triple‐negative subtype, and highe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toss, Angela, Ponzoni, Ornella, Riccò, Beatrice, Piombino, Claudia, Moscetti, Luca, Combi, Francesca, Palma, Enza, Papi, Simona, Tenedini, Elena, Tazzioli, Giovanni, Dominici, Massimo, Cortesi, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444947/ https://www.ncbi.nlm.nih.gov/pubmed/37621724 http://dx.doi.org/10.1002/ccr3.7747

Ejemplares similares

Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers
por: Toss, Angela, et al.
Publicado: (2021)

Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy
por: Toss, Angela, et al.
Publicado: (2022)

Personalized Systemic Therapies in Hereditary Cancer Syndromes
por: Mastrodomenico, Luciana, et al.
Publicado: (2023)

Breast tuberculosis: A case report of primary type mammary tuberculosis
por: Tazzioli, Giovanni, et al.
Publicado: (2019)

Ewing’s Sarcoma of the Breast in a Young Woman: A Case Report and Review of the Literature
por: Papi, Simona, et al.
Publicado: (2022)

Male mammary myofibroblastoma: Two case reports and brief review of literature
por: Venturelli, Marta, et al.
Publicado: (2020)

Management of nipple adenomas during pregnancy: a case report
por: Combi, Francesca, et al.
Publicado: (2023)

Application of OSNA Nomogram in Patients With Macrometastatic Sentinel Lymph Node: A Retrospective Assessment of Accuracy
por: Combi, Francesca, et al.
Publicado: (2021)

BRCA Detection Rate in an Italian Cohort of Luminal Early-Onset and Triple-Negative Breast Cancer Patients without Family History: When Biology Overcomes Genealogy
por: Toss, Angela, et al.
Publicado: (2020)

Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature
por: Isca, Chrystel, et al.
Publicado: (2021)

Germline Mutations in Other Homologous Recombination Repair-Related Genes Than BRCA1/2: Predictive or Prognostic Factors?
por: Cortesi, Laura, et al.
Publicado: (2021)

Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials
por: Omarini, Claudia, et al.
Publicado: (2020)

Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA
por: Piombino, Claudia, et al.
Publicado: (2020)

Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications
por: Toss, Angela, et al.
Publicado: (2018)

Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review
por: Canino, Fabio, et al.
Publicado: (2022)

The Role of Exosomes in Breast Cancer Diagnosis
por: Piombino, Claudia, et al.
Publicado: (2021)

Lifestyle Intervention on Body Weight and Physical Activity in Patients with Breast Cancer Can Reduce the Risk of Death in Obese Women: The EMILI Study
por: Cortesi, Laura, et al.
Publicado: (2020)

Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era
por: Toss, A., et al.
Publicado: (2021)

The Prognostic and Predictive Role of Somatic BRCA Mutations in Ovarian Cancer: Results from a Multicenter Cohort Study
por: Toss, Angela, et al.
Publicado: (2021)

Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy
por: Omarini, Claudia, et al.
Publicado: (2020)

Insights into the Possible Molecular Mechanisms of Resistance to PARP Inhibitors
por: Piombino, Claudia, et al.
Publicado: (2022)

Are you treating ypN0 patient with adjuvant abemaciclib?
por: Toss, A., et al.
Publicado: (2023)

Germline PALB2 Mutations in Cancers and Its Distinction From Somatic PALB2 Mutations in Breast Cancers
por: Hu, Zhe-Yu, et al.
Publicado: (2020)

Quality of life of therapies for hormone receptor positive advanced/metastatic breast cancer: Regulatory aspects and clinical impact in Europe
por: Moscetti, L., et al.
Publicado: (2021)

Breast ultrasound in high-risk women
por: Cortesi, Laura, et al.
Publicado: (2019)

PALB2 (partner and localizer of BRCA2)
por: Hanenberg, Helmut, et al.
Publicado: (2018)

Surgery for BRCA, TP53 and PALB2: a literature review
por: Song, Chin-Vern, et al.
Publicado: (2018)

Meta-Analysis of Breast Cancer Risk for Individuals with PALB2 Pathogenic Variants
por: Ruberu, Thanthirige Lakshika M., et al.
Publicado: (2023)

PALB2 and breast cancer: ready for clinical translation!
por: Southey, Melissa C, et al.
Publicado: (2013)

PALB2 self-interaction controls homologous recombination
por: Buisson, Rémi, et al.
Publicado: (2012)

The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life
por: Grandi, Giovanni, et al.
Publicado: (2015)

Optimizing the Continuum of Care in Gastric Cancer
por: Riccò, Beatrice, et al.
Publicado: (2023)

Enhancement of the RAD51 Recombinase Activity by the Tumor Suppressor PALB2
por: Dray, Eloïse, et al.
Publicado: (2010)

Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going
por: Omarini, Claudia, et al.
Publicado: (2018)

Assessment of PALB2 as a Candidate Melanoma Susceptibility Gene
por: Aoude, Lauren G., et al.
Publicado: (2014)

Tumour morphology predicts PALB2 germline mutation status
por: Teo, Z L, et al.
Publicado: (2013)

The Role of PALB2 in the DNA Damage Response and Cancer Predisposition
por: Nepomuceno, Thales C., et al.
Publicado: (2017)

Functional characterization of 84 PALB2 variants of uncertain significance
por: Wiltshire, Timothy, et al.
Publicado: (2019)

Structural Insight into the Mechanism of PALB2 Interaction with MRG15
por: Redington, Jennifer, et al.
Publicado: (2021)

The PALB2 DNA-binding domain is an intrinsically disordered recombinase
por: Kyriukha, Yevhenii, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k1s1ui03d41fp78d8e6212thpn